| | Characteristics | Non-CR (N = 27) | CR (N = 40) | value |
| | Age, years# | 59.33 ± 10.48 | 70.48 ± 11.38 | <0.001 | | Height (m)# | 1.70 ± 0.08 | 1.67 ± 0.09 | 0.115 | | Weight (Kg)# | 69.04 ± 9.93 | 68.78 ± 11.86 | 0.925 | | BMI (Kg/m2)# | 23.60 ± 2.13 | 24.59 ± 3.04 | 0.151 | | Oxygen saturation (%) | 91.0 (89.0, 93.0) | 90.5 (89.3, 93.0) | 0.892 | | SBP (mmHg)# | 129.6 ± 28.1 | 128.1 ± 17.7 | 0.809 | | DBP (mmHg)# | 75.0 ± 14.1 | 73.2 ± 11.0 | 0.549 | | Heart rate# | 77.7 ± 14.2 | 79.1 ± 15.7 | 0.699 | | White blood cell | 7.17 (5.55, 10.53) | 6.93 (5.48, 11.06) | 0.898 | | Red blood cell | 5.10 (4.55, 5.55) | 4.60 (4.25, 5.26) | 0.120 | | Hemoglobin# | 158.5 ± 22.1 | 149.7 ± 20.6 | 0.098 | | Glycosylated hemoglobin | 5.57 (5.38, 5.97) | 6.09 (5.49, 7.24) | 0.009 | | PT | 11.9 (11.6, 12.7) | 11.7 (11.2, 12.5) | 0.169 | | APTT | 27.9 (26.7, 30.9) | 26.5 (24.5, 30.0) | 0.031 | | ALT | 33.0 (20.0, 70.0) | 27.0 (18.3, 39.5) | 0.125 | | AST | 60.0 (22.0, 209.0) | 31.0 (20.0, 121.5) | 0.179 | | AST/ALT | 1.4 (1.0, 3.4) | 1.2 (0.8, 2.4) | 0.315 | | Urea nitrogen | 5.41 (4.86, 7.54) | 6.11 (5.25, 7.63) | 0.201 | | Creatinine | 78.0 (67.0, 90.0) | 84.5 (67.0, 93.0) | 0.908 | | Glomerular filtration rate (mL/min × 1.73 m2)# | 87.4 ± 28.3 | 75.9 ± 21.5 | 0.064 | | Albumin | 38.6 (36.1, 41.4) | 37.8 (35.2, 40.0) | 0.457 | | Total cholesterol (mmol/L)# | 4.07 ± 1.02 | 4.16 ± 1.04 | 0.731 | | Triglyceride | 1.29 (0.90, 1.97) | 1.77 (0.90, 2.51) | 0.315 | | TSH | 1.79 (0.66, 2.65) | 1.62 (1.15, 2.81) | 0.498 |
| | Sex, n (%) | | | 0.010 | | Male | 23 (85.2) | 22 (55.0) | | | Female | 4 (14.8) | 18 (45.0) | |
| | Aspirin resistance, n (%) | | | <0.001 | | No | 20 (74.1) | 10 (25.0) | | | Yes | 7 (25.9) | 30 (75.0) | |
| | Smoking history, n (%) | | | 0.065 | | No | 10 (37.0) | 24 (60.0) | | | Yes | 17 (63.0) | 16 (40.0) | |
| | Coronary heart disease type, n (%) | | | 0.206 | | STEMI | 14 (51.9) | 17 (42.5) | | | NSTEMI | 5 (18.5) | 3 (7.5) | | | SAP | 2 (7.4) | 9 (22.5) | | | UA | 6 (22.2) | 11 (27.5) | |
| | Hypertension, n (%) | | | 0.110 | | No | 11 (40.7) | 9 (22.5) | | | Yes | 16 (59.3) | 31 (77.5) | |
| | Diabetes, n (%) | | | 0.003 | | No | 20 (74.1) | 15 (37.5) | | | Yes | 7 (25.9) | 25 (62.5) | |
| | Stroke, n (%) | | | 0.969 | | No | 17 (63.0) | 25 (62.5) | | | Yes | 10 (37.0) | 15 (37.5) | |
| | Hyperlipidaemia, n (%) | | | 0.570 | | No | 15 (55.6) | 25 (62.5) | | | Yes | 12 (44.4) | 15 (37.5) | |
| | CYP2C192, n (%) | | | 0.333 | | GG | 16 (59.3) | 29 (72.5) | | | GA | 7 (25.9) | 9 (22.5) | | | AA | 4 (14.8) | 2 (5.0) | |
| | CYP2C192, n (%) | | | 0.258 | | GG | 16 (59.3) | 29 (72.5) | | | GA + AA | 11 (40.7) | 11 (27.5) | |
| | CYP2C193, n (%) | | | 0.216 | | GG | 17 (63.0) | 17 (42.5) | | | GA | 6 (22.2) | 11 (27.5) | | | AA | 4 (14.8) | 12 (30.0) | |
| | CYP2C193, n (%) | | | 0.100 | | GG | 17 (63.0) | 17 (42.5) | | | GA + AA | 10 (37.0) | 23 (57.5) | |
| | CYP2C1917, n (%) | | | 0.888 | | GG | 18 (66.7) | 26 (65.0) | | | GA | 9 (33.3) | 14 (35.0) | |
|
|
